X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10755) 10755
Newsletter (136) 136
Book Chapter (50) 50
Book / eBook (20) 20
Magazine Article (19) 19
Conference Proceeding (7) 7
Dissertation (5) 5
Publication (4) 4
Transcript (3) 3
Web Resource (3) 3
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aminoglycosides (5177) 5177
humans (4910) 4910
anti-bacterial agents - pharmacology (4841) 4841
pharmacology & pharmacy (3291) 3291
aminoglycosides - pharmacology (2910) 2910
microbiology (2699) 2699
animals (2668) 2668
microbial sensitivity tests (2492) 2492
antibiotics (1771) 1771
male (1667) 1667
female (1445) 1445
gentamicin (1366) 1366
infectious diseases (1329) 1329
drug resistance, microbial (1102) 1102
anti-bacterial agents - therapeutic use (1080) 1080
gentamicins - pharmacology (1079) 1079
aminoglycoside antibiotics (919) 919
anti-bacterial agents - administration & dosage (851) 851
pseudomonas aeruginosa - drug effects (790) 790
bacteria (782) 782
adult (776) 776
aminoglycoside (723) 723
middle aged (708) 708
biochemistry & molecular biology (704) 704
mice (703) 703
infections (682) 682
rats (682) 682
aminoglycosides - therapeutic use (665) 665
research article (661) 661
escherichia coli - drug effects (649) 649
bacteria - drug effects (646) 646
analysis (644) 644
escherichia-coli (639) 639
aged (628) 628
anti-bacterial agents - pharmacokinetics (617) 617
drug resistance in microorganisms (596) 596
anti-bacterial agents - chemistry (582) 582
drug resistance, bacterial (580) 580
staphylococcus aureus - drug effects (575) 575
resistance (570) 570
drug resistance (569) 569
dose-response relationship, drug (566) 566
research (551) 551
pharmacokinetics (543) 543
anti-bacterial agents - metabolism (524) 524
anti-bacterial agents - adverse effects (510) 510
molecular sequence data (510) 510
drug synergism (492) 492
genes (470) 470
aminoglycosides - metabolism (457) 457
aminoglycosides - administration & dosage (451) 451
mutation (446) 446
amikacin (444) 444
antibacterial agents (444) 444
kinetics (437) 437
nephrotoxicity (431) 431
time factors (418) 418
vancomycin (417) 417
health aspects (416) 416
bacterial infections - drug therapy (408) 408
pseudomonas-aeruginosa (407) 407
bacterial proteins - genetics (402) 402
immunology (401) 401
tobramycin (399) 399
biochemical phenomena, metabolism, and nutrition (390) 390
biotechnology & applied microbiology (390) 390
antibiotic resistance (385) 385
antimicrobial resistance (383) 383
aminoglycosides - chemistry (379) 379
therapy (375) 375
amikacin - pharmacology (365) 365
chemistry, medicinal (365) 365
structure-activity relationship (359) 359
pharmacology (358) 358
escherichia coli - genetics (346) 346
adolescent (339) 339
antimicrobial agents (339) 339
base sequence (339) 339
identification (339) 339
in-vitro (335) 335
tobramycin - pharmacology (335) 335
plasmids (330) 330
susceptibility (330) 330
aminoglycosides - adverse effects (329) 329
pseudomonas aeruginosa (328) 328
gentamicins - administration & dosage (325) 325
toxicology (325) 325
ciprofloxacin (323) 323
cephalosporins - pharmacology (316) 316
aminoglycoside resistance (309) 309
anti-bacterial agents - toxicity (307) 307
anti-bacterial agents (306) 306
prevalence (306) 306
hospitals (305) 305
oncology (304) 304
in vitro techniques (301) 301
anti-bacterial agents - blood (297) 297
drugs (295) 295
antibiotic-resistance (291) 291
infection (291) 291
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10365) 10365
Japanese (534) 534
French (138) 138
Spanish (91) 91
Russian (86) 86
German (71) 71
Chinese (56) 56
Italian (40) 40
Polish (29) 29
Turkish (11) 11
Romanian (9) 9
Ukrainian (8) 8
Portuguese (6) 6
Czech (5) 5
Slovak (4) 4
Hungarian (3) 3
Croatian (2) 2
Danish (2) 2
Dutch (2) 2
Finnish (2) 2
Serbian (2) 2
Bulgarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2018, Volume 63, Issue 1
The determination of antibiotic potency against bacterial strains by assessment of their minimum inhibitory concentration normally uses a standardized broth... 
Broth microdilution assay | Additive effects | MIC | Microtiter plate effects | TESTING METHODS | SERUM-PROTEIN BINDING | ESCHERICHIA-COLI | broth microdilution assay | microtiter plate effects | MICROBIOLOGY | POLYMYXIN-B | CONTROL STRAINS | ACINETOBACTER-BAUMANNII | BACTERICIDAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | additive effects | PHARMACOLOGY & PHARMACY | STAPHYLOCOCCUS-AUREUS | KLEBSIELLA-PNEUMONIAE | Polymyxin B - pharmacology | Trimethoprim - chemistry | Trimethoprim - pharmacology | Rifampin - chemistry | Escherichia coli - drug effects | Depsipeptides - pharmacology | Vancomycin - chemistry | Colistin - pharmacology | Polysorbates - pharmacology | Anti-Bacterial Agents - chemistry | Vancomycin - pharmacology | Escherichia coli - metabolism | Teicoplanin - pharmacology | Plastics - chemistry | Escherichia coli - growth & development | Lipoglycopeptides - pharmacology | Culture Media - chemistry | Lipoglycopeptides - chemistry | Microbial Sensitivity Tests - instrumentation | Teicoplanin - analogs & derivatives | Depsipeptides - chemistry | Polymyxin B - chemistry | Calcium - pharmacology | Colistin - chemistry | Methicillin-Resistant Staphylococcus aureus - drug effects | Oxacillin - pharmacology | Penicillin G - chemistry | Teicoplanin - chemistry | Ciprofloxacin - pharmacology | Aminoglycosides - chemistry | Factor Analysis, Statistical | Penicillin G - pharmacology | Methicillin-Resistant Staphylococcus aureus - growth & development | Methicillin-Resistant Staphylococcus aureus - metabolism | Culture Media - pharmacology | Ciprofloxacin - chemistry | Anti-Bacterial Agents - pharmacology | Oxacillin - chemistry | Rifampin - pharmacology | Aminoglycosides - pharmacology
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 4, pp. 328 - 341
Summary Background Many meta-analyses have shown reductions in infection rates and mortality associated with the use of selective digestive decontamination... 
Infectious Disease | MULTIPLE-TRAUMA PATIENTS | CONTROLLED CLINICAL-TRIAL | RANDOMIZED CONTROLLED-TRIALS | INFECTIOUS DISEASES | VENTILATOR-ASSOCIATED PNEUMONIA | DOUBLE-BLIND | OROPHARYNGEAL DECONTAMINATION | PLACEBO-CONTROLLED TRIAL | NOSOCOMIAL INFECTION | DIGESTIVE-TRACT DECONTAMINATION | CRITICALLY-ILL PATIENTS | United States - epidemiology | Prevalence | Gram-Positive Bacteria - drug effects | Humans | Tobramycin - pharmacology | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Disease Transmission, Infectious - prevention & control | Cross Infection - transmission | Polymyxins - pharmacology | Digestive System - drug effects | Decontamination | Gentamicins - pharmacology | Vancomycin - pharmacology | Neomycin - pharmacology | Nystatin - pharmacology | Odds Ratio | Cephalosporins - pharmacology | Cross Infection - epidemiology | Oropharynx - microbiology | Anti-Infective Agents, Local - pharmacology | Cross Infection - prevention & control | Methicillin-Resistant Staphylococcus aureus - drug effects | South Africa - epidemiology | Amphotericin B - pharmacology | Europe - epidemiology | Clinical Trials as Topic | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Randomized Controlled Trials as Topic | Gram-Negative Bacteria - drug effects | Anti-Infective Agents, Local - administration & dosage | Cross Infection - microbiology | Fluoroquinolones - pharmacology | Enterobacteriaceae - drug effects | Primary Prevention - methods | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Anti-Bacterial Agents - administration & dosage | Digestive System - microbiology | Oropharynx - drug effects | Drug resistance in microorganisms | Analysis
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2014, Volume 58, Issue 3, pp. 1757 - 1762
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2007, Volume 51, Issue 1, pp. 231 - 238
Journal Article
Apoptosis, ISSN 1360-8185, 4/2013, Volume 18, Issue 4, pp. 393 - 408
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2011, Volume 55, Issue 10, pp. 4619 - 4630
A pharmacokinetic-pharmacodynamic (PKPD) model that characterizes the full time course of time-kill curve experiments of antibacterial drugs was here evaluated... 
VITRO DYNAMIC-MODEL | STREPTOCOCCUS-PNEUMONIAE | PHARMACODYNAMIC MODEL | POPULATION PHARMACOKINETICS | PSEUDOMONAS-AERUGINOSA | ADAPTIVE RESISTANCE | IN-VIVO | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MONTE-CARLO SIMULATIONS | AMINOGLYCOSIDE ANTIBIOTICS | RESPIRATORY-TRACT INFECTIONS | Fluoroquinolones | Aza Compounds - pharmacokinetics | Area Under Curve | Erythromycin - pharmacology | Escherichia coli - drug effects | Humans | Cefuroxime - pharmacology | Aza Compounds - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Anti-Bacterial Agents - therapeutic use | Gentamicins - pharmacology | Computer Simulation | Vancomycin - pharmacology | Streptococcus pyogenes - drug effects | Gentamicins - pharmacokinetics | Penicillin G - pharmacology | Erythromycin - pharmacokinetics | Cefuroxime - pharmacokinetics | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Penicillin G - pharmacokinetics | Drugs | Subpopulations | Pharmacodynamics | Gentamicin | Benzylpenicillin | Erythromycin | Moxifloxacin | Regression analysis | Vancomycin | Drug development | Cefuroxime | Antibiotics | Minimum inhibitory concentration | Models | Pharmacokinetics | Experimental Therapeutics
Journal Article